参考文献/References:
[1]Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015. CA Cancer J Clin,2016,66(2):115-132.
[2]Koelzer VH, Langer R, Zlobec I, et al. Tumor budding in upper gastrointestinal carcinomas. Front Oncol,2014,4:216.
[3]Chen XL, Yang K, Zhang WH, et al. Metastasis, risk factors and prognostic significance of splenic hilar lymph nodes in gastric adenocarcinoma. PLoS One,2014,9(6):e99650.
[4]Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med,2004,22(4):275-282.
[5]Seevaratnam R, Cardoso R, McGregor C, et al. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer,2012,15(Suppl 1):S3-S18.
[6]Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol,2007,25(15):2107-2116.
[7]Ma M, Chen S, Zhu BY, et al. The clinical significance and risk factors of solitary lymph node metastasis in gastric cancer. PLoS One,2015,10(1):e0114939.
[8]Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg,2011,35(4):895-899.
[9]Zhou J, Zhan S, Zhu Q, et al. Prediction of nodal involvement in primary rectal carcinoma without invasion to pelvic structures: accuracy of preoperative CT, MR, and DWIBS assessments relative to histopathologic findings. PLoS One,2014,9(4):e92779.
[10]Xu HW, Ren F, Chen W, et al. Osseous metastasis of cutaneous squamous cell carcinoma treated successfully with oxaliplatin, tegafur and leucovorin combination chemotherapy: a case report. Int J Clin Exp Med,2012,5(1):87-91.
[11]Kim DJ,Chung JJ,Yu JS,et al.Evaluation of lateral pelvic nodes in patients with advanced rectal caner.AJR Am J Roentgenol,2014,202(6):1245-1255.
[12]徐艳琦，徐芹艳，孙西河，等.全身磁共振背景抑制扩散成像对胃癌原发灶筛查及N 分期的价值.临床放射学杂志,2012,31（12）：1741-1745.
[13]庄晓曌，余深平，崔冀,等.3.0 T磁共振背景抑制弥散加权成像对直肠癌淋巴结转移的诊断价值.中华胃肠外科杂志,2011,14(11):842-845.
[14]魏来，朱荆皓，彭屹峰.磁共振全身弥散成像对胃肠道恶性肿瘤的术后随访价值. 磁共振成像,2016,11（7）：847-850.
[15]Gong J, Cao W, Zhang Z, et al. Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer. Gastroenteroly Rep,2015,3(2):128-135.
[16]Sharma A, Young M. Impact of PET-CT scan on management in upper gastrointestinal malignancy. N Z Med J,2016,129(1437):39-47.
[17]Park K, Jang G, Baek S, et al. Usefulness of combined PET/CT to assess regional lymph node involvement in gastric cancer. Tumori,2014,100(2):201-206.
[18]Yun M. Imaging of gastric cancer metabolism using 18F-FDG PET/CT. J Gastric Cancer,2014,14(1):1-6.
[19]Malibari N, Hickeson M, Lisbona R. PET/computed tomography in the diagnosis and staging of gastric cancers.PET Clin,2015,10(3):311-326.
[20]潘云云，汪灏,冯敏,等.胃癌转移性淋巴结放射免疫示踪的现状与进展.中华胃肠外科杂志,2015,18(3):298-300.
[21]Kim JC, Hong HK, Roh SA, et al. Efficient targeting of gastric cancer cells using radiolabeled anti-carcinoembryonic antigen-specific T84.66 fragments in experimental radioimmunoguided surgery. Anticancer Res,2004,24(2B):663-670.
[22]王川，王怡，苏向前，等．１２５I 标记抗胃癌单克隆抗体３Ｈ１１在胃癌放射免疫导向手术中应用的初步研究.中华外科杂志,2000,38(7):26-28．
[23]Pazo Cid RA, Antón A. Advanced HER2-positive gastric cancer: current and future targeted therapies. Crit Rev Oncol Hematol,2013,85(3):350-362.
[24]Cidon EU, Ellis SG, Inam Y, et al. Molecular targeted agents for gastric cancer: a step forward towards personalized therapy. Cancers (Basel), 2013,5(1):64-91.
[25]许洪卫，蔡诚忠，谭龙益.胃癌根治手术与血清、组织E-钙粘附素变化的关系.中华实验外科杂志,2003,20（8）:751-752.
[26]Xu HW, Ren F, Yu YM，et al. Runx3 expression in the lymph nodes with metastasis is associated with outcome of gastric cancer patients. Oncol Lett,2011,2(6):1275-1279.
[27]Gainkam LO, Huang L, Caveliers V, et al.Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. J Nucl Med,2008,49(5):788-795.
[28]Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z. Nanobody: an old concept and new vehicle for immunotargeting. Immunol Invest,2011,40(3):299-338.
[29]Oliveira S, van Dongen GA, Stigter-van Walsum M, et al. Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody. Mol Imaging,2012,11(1):33-46.